fresh and frozen whole leukaphereses

Key Biologics Accelerates CAR-T Research with New Leukaphereses Offerings

Also announces installation of Asymptote VIA Quad Freeze controlled-rate freezer MEMPHIS, TN, and MONTREAL QC, May 14, 2018 – Key Biologics LLC , a provider of biological raw materials and services for manufacturing cell-based therapeutics, today announced the availability of fresh and frozen whole leukaphereses from patients with hematologic malignancies; Multiple Myeloma, Non-Hodgkin Lymphoma, Chronic…